Abiopharma

Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Air Products and Chemicals, Inc. - APD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

HALEON PLC (HLN) Files Form 6-K

New Form 25-NSE - QIAGEN N.V. Filed: 2026-01-08 AccNo: 0000876661-26-000016 Size: 4 KB

📋 Hui Yvonne (Officer) plans to sell 372 shares of Phreesia, Inc. (at $17.47 each, total $6K) Filed: Jan 08, 2026 | ID: 000202

New Form SCHEDULE 13G/A - 10x Genomics, Inc. Filed: 2026-01-08 AccNo: 0000315066-26-000056 Size: 14 KB

New Form SCHEDULE 13G/A - VERACYTE, INC. Filed: 2026-01-08 AccNo: 0001104659-26-001972 Size: 13 KB